PharmD / MS医疗保健决策分析计划是一项综合的双学位计划，其中通过对商业智能，健康经济学和医疗保健政策的实际了解和应用技能来加强药学教育。该计划为在国内和国际药品的覆盖，获取，报销和定价领域进行高级准备提供了机会。毕业生特别准备在制药行业，管理式医疗，医疗保健系统，咨询和政府部门寻求职业。
The Healthcare Decision Analysis (HCDA) program gives students the tools and knowledge to succeed in the complex world of healthcare data analytics, international access and reimbursement, product pricing and value assessment, insurance operations and design, along with competitive business intelligence. A dual degree of Doctor of Pharmacy and Master of Science in Healthcare Decision Analysis will be granted upon the completion of the course work required for the PharmD degree, and the HCDA core and elective units. Dual degree students will be credited up to 9 units of appropriate PharmD course work toward the MS, HCDA. Dual degree students will select from a series of HCDA core courses and required electives to meet the MS, HCDA degree requirements. Electives will be considered from the disciplines: applied healthcare policy, business intelligence, regulatory science, and healthcare economics, along with all required clerkships and rotations offered though the USC School of Pharmacy.